# Beximco Pharmaceuticals Limited – FDA Inspection, Mar 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/beximco-pharmaceuticals-limited/fca6aa82-6dd0-4a6c-aa6d-d2449b480320
Source feed: FDA_Inspections

> FDA inspection 1201162 of Beximco Pharmaceuticals Limited, March 30, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201162
- Company Name: Beximco Pharmaceuticals Limited
- Inspection Date: 2023-03-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 914961 - 2015-01-22

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gam-s-zamil/75bc04d4-6013-43b5-8200-8b513c814a7c)

Company: https://www.keypedia.com/companies/beximco-pharmaceuticals-limited/1e6f8a78-2764-4bc4-b91e-0b37ae1ac008

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c